Correlation Between Sensata Technologies and SBC Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sensata Technologies and SBC Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sensata Technologies and SBC Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sensata Technologies Holding and SBC Medical Group, you can compare the effects of market volatilities on Sensata Technologies and SBC Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sensata Technologies with a short position of SBC Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sensata Technologies and SBC Medical.

Diversification Opportunities for Sensata Technologies and SBC Medical

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sensata and SBC is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Sensata Technologies Holding and SBC Medical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SBC Medical Group and Sensata Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sensata Technologies Holding are associated (or correlated) with SBC Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SBC Medical Group has no effect on the direction of Sensata Technologies i.e., Sensata Technologies and SBC Medical go up and down completely randomly.

Pair Corralation between Sensata Technologies and SBC Medical

Allowing for the 90-day total investment horizon Sensata Technologies Holding is expected to under-perform the SBC Medical. But the stock apears to be less risky and, when comparing its historical volatility, Sensata Technologies Holding is 6.79 times less risky than SBC Medical. The stock trades about -0.02 of its potential returns per unit of risk. The SBC Medical Group is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  7.31  in SBC Medical Group on October 1, 2024 and sell it today you would earn a total of  17.69  from holding SBC Medical Group or generate 242.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy24.91%
ValuesDaily Returns

Sensata Technologies Holding  vs.  SBC Medical Group

 Performance 
       Timeline  
Sensata Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sensata Technologies Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
SBC Medical Group 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SBC Medical Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, SBC Medical showed solid returns over the last few months and may actually be approaching a breakup point.

Sensata Technologies and SBC Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sensata Technologies and SBC Medical

The main advantage of trading using opposite Sensata Technologies and SBC Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sensata Technologies position performs unexpectedly, SBC Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SBC Medical will offset losses from the drop in SBC Medical's long position.
The idea behind Sensata Technologies Holding and SBC Medical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance